Table 1. Clinical trials on the use of bacteriophages to treat bacterial infections.
Indication | Study type | Result | Reference |
Chronic venous leg ulcers | Monocentric, placebo-controlled phase-I study |
No evidence of relevant side effects |
Rhoads et al., 2009 (e14) |
Chronic otitis due to multidrug-resistant Pseudomonas aeruginosa | Monocentric, randomized, double-blind, placebo-controlled phase-I/-II study |
– No evidence of relevant side effects – Significant symptom reduction in the treatment arm |
Wright et al., 2009 (e15) |
Burn wounds colonized with Staphylococcus aureus and Pseudomonas aeruginosa |
Monocentric, placebo-controlled phase-I study |
No evidence of relevant side effects | Rose et al., 2014 (e16) |
Escherichia coli–associated diarrhea in childhood |
Monocentric, placebo-controlled phase-II study |
– No evidence of relevant side effects – No significant symptom reduction in the treatment arm |
Sarker et al., 2016 (e17) |
Chronic rhinosinusitis due to Staphylococcus aureus |
Open-label phase-I study | – No evidence of relevant side effects – Microbial and clinical response in 22.2 % of treated patients (2/9) |
Ooi et al., 2019 (e18) |